US 2014/0179625 A1 · SODIUM CHANNEL BLOCKERS

Abstract

The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.

Claims2

Dependent claims

1-208. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

14/158,441Filed 17 Jan 2014

Priority

19 Feb 2002

Published

26 Jun 2014

Term ends

Not estimatedThe source records don’t support an estimate.

Classification37 codes

A61K 31/4965
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed pyrazines
A61K 31/497
Non-condensed pyrazines: containing further heterocyclic rings
A61K 31/706
Having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides: containing six-membered rings with nitrogen as a ring hetero atom
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application10/076,571Continuation in part · filed 19 Feb 2002

Application10/532,110Continuation · filed 21 Apr 2005

Application12/179,353Continuation · filed 24 Jul 2008

Application13/492,711Continuation · filed 8 Jun 2012

Application14/158,441Continuation

Application10/532,110Continuation in part

US 2003/0199456 A1Published application

US 2006/0142306 A1Published application

US 2009/0227530 A1Published application

US 2013/0012692 A1Published application

US 6,858,615 B2Related patent

US 8,198,286 B2Related patent

US 8,846,688 B2Related patent

US 2014/0179625 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.

Facts

Application

14/158,441Filed 17 Jan 2014

Priority

19 Feb 2002

Published

26 Jun 2014

Term ends

Not estimatedThe source records don’t support an estimate.

Classification37 codes

A61K 31/4965
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed pyrazines
A61K 31/497
Non-condensed pyrazines: containing further heterocyclic rings
A61K 31/706
Having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides: containing six-membered rings with nitrogen as a ring hetero atom
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application10/076,571Continuation in part · filed 19 Feb 2002

Application10/532,110Continuation · filed 21 Apr 2005

Application12/179,353Continuation · filed 24 Jul 2008

Application13/492,711Continuation · filed 8 Jun 2012

Application14/158,441Continuation

Application10/532,110Continuation in part

US 2003/0199456 A1Published application

US 2006/0142306 A1Published application

US 2009/0227530 A1Published application

US 2013/0012692 A1Published application

US 6,858,615 B2Related patent

US 8,198,286 B2Related patent

US 8,846,688 B2Related patent

US 2014/0179625 A1This patent

From the US filing history. Foreign family members aren’t listed.

Sodium channel blockers

Life of this patent

Abstract

Claims2

Sodium channel blockers

Life of this patent

Abstract

Claims2